Renee Tannenbaum, BSc, PharmD, MBA, Vice President, Global Partnering

Dr. Tannenbaum has more than 30 years of operating and general management experience in the biopharmaceutical industry, including broad global drug development and commercialization experience. Dr. Tannenbaum joined Halozyme in August 2016 as Vice President, Global Alliance Management. She is responsible for the overall relationship and program execution for the company’s strategic alliances with the ENHANZE® drug delivery technology. In addition, she also oversees the company’s business development activities.

Prior to joining Halozyme, Dr. Tannenbaum held several senior roles, including Head of Global Customer Excellence at AbbVie, Vice President and Chief Commercial Officer at Elan Pharmaceuticals, Inc., Head of Global Commercial Operations at Novartis AG and Vice President of ConVaTec Americas, a Bristol-Myers Squibb corporation.

Dr. Tannenbaum received her MBA from Temple University School of Business, her Pharm.D. at the Philadelphia College of Pharmacy and Sciences, and her B.Sc. degree from the University of Connecticut School of Pharmacy. She currently serves as Adjunct Professor at the University of the Sciences at Philadelphia and serves on the Board of Directors at Zogenix, Inc.


You are now leaving Halozyme is not responsible for or endorses the content of the linked site.